- Home
- PLUR
PLUR
Pluri Inc.
as 07-26-2024 4:00pm EST
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility.
| Founded: | 2001 | Country: | Israel |
| Employees: | N/A | City: | HAIFA |
| Market Cap: | 30.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 5.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.13 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.44 - $8.48 | Next Earning Date: | 09-10-2024 |
| Revenue: | $341,000 | Revenue Growth: | 93.75% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Pluri Inc. News
PLUR Breaking Stock News: Dive into PLUR Ticker-Specific Updates for Smart Investing
MT Newswires
8 days ago
Pluri Shares Rise After Manufacturing Accord With Kadimastem Set
GlobeNewswire
9 days ago
Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates
GlobeNewswire
19 days ago
Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply
MT Newswires
24 days ago
Pluri Appoints Liat Zalts as CFO
MT Newswires
a month ago
Sector Update: Consumer
MT Newswires
a month ago
Pluri's Ever After Foods Subsidiary Gets $10 Million Investment; Shares Rise
GlobeNewswire
a month ago
Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges
GlobeNewswire
2 months ago
U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract
Compare PLUR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PLUR Pluri Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.